Literature DB >> 15733666

Normal patterning of the coronary capillary plexus is dependent on the correct transmural gradient of FGF expression in the myocardium.

David J Pennisi1, Takashi Mikawa.   

Abstract

The formation of the coronary vessel system is vital for heart development, an essential step of which is the establishment of a capillary plexus that displays a density gradient across the myocardial wall, being higher on the epicardial than the endocardial side. This gradient in capillary plexus formation develops concurrently with transmural gradients of myocardium-derived growth factors, including FGFs. To test the role of the FGF expression gradient in patterning the nascent capillary plexus, an ectopic FGF-over-expressing site was created in the ventricular myocardial wall in the quail embryo via retroviral infection from E2-2.5, thus abolishing the transmural gradient of FGFs. In FGF virus-infected regions of the ventricular myocardium, the capillary density across the transmural axis shifted away from that in control hearts at E7. This FGF-induced change in vessel patterning was more profound at E12, with the middle zone becoming the most vascularized. An up-regulation of FGFR-1 and VEGFR-2 in epicardial and subepicardial cells adjacent to FGF virus-infected myocardium was also detected, indicating a paracrine effect on induction of vascular signaling components in coronary precursors. These results suggest that correct transmural patterning of coronary vessels requires the correct transmural expression of FGF and, therefore, FGF may act as a template for coronary vessel patterning.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15733666     DOI: 10.1016/j.ydbio.2004.12.028

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  12 in total

Review 1.  Electrophysiological patterning of the heart.

Authors:  Bastiaan J Boukens; Vincent M Christoffels
Journal:  Pediatr Cardiol       Date:  2012-02-25       Impact factor: 1.655

Review 2.  Epicardial-myocardial signaling directing coronary vasculogenesis.

Authors:  Harold E Olivey; Eric C Svensson
Journal:  Circ Res       Date:  2010-03-19       Impact factor: 17.367

3.  Sema3D, Sema3F, and Sema5A are expressed in overlapping and distinct patterns in chick embryonic heart.

Authors:  Zhe Jin; Mary D Chau; Zheng-Zheng Bao
Journal:  Dev Dyn       Date:  2006-01       Impact factor: 3.780

Review 4.  Signals from both sides: Control of cardiac development by the endocardium and epicardium.

Authors:  Travis K Smith; David M Bader
Journal:  Semin Cell Dev Biol       Date:  2006-12-29       Impact factor: 7.727

5.  Alterations in retinoic acid signaling affect the development of the mouse coronary vasculature.

Authors:  Suya Wang; Weiliang Huang; Hozana A Castillo; Maureen A Kane; José Xavier-Neto; Paul A Trainor; Alexander R Moise
Journal:  Dev Dyn       Date:  2018-08       Impact factor: 3.780

6.  Embryonic coronary vasculogenesis and angiogenesis are regulated by interactions between multiple FGFs and VEGF and are influenced by mesenchymal stem cells.

Authors:  Robert J Tomanek; Lance P Christensen; Michael Simons; Masahiro Murakami; Wei Zheng; Gina C Schatteman
Journal:  Dev Dyn       Date:  2010-12       Impact factor: 3.780

Review 7.  The Role of the Epicardium During Heart Development and Repair.

Authors:  Pearl Quijada; Michael A Trembley; Eric M Small
Journal:  Circ Res       Date:  2020-01-30       Impact factor: 17.367

8.  FGFR-1 is required by epicardium-derived cells for myocardial invasion and correct coronary vascular lineage differentiation.

Authors:  David J Pennisi; Takashi Mikawa
Journal:  Dev Biol       Date:  2009-01-27       Impact factor: 3.582

9.  Generation of controllable gradients in cell density.

Authors:  Wenying Liu; Yu Zhang; Stavros Thomopoulos; Younan Xia
Journal:  Angew Chem Int Ed Engl       Date:  2012-09-05       Impact factor: 15.336

Review 10.  Epicardium in Heart Development.

Authors:  Yingxi Cao; Sierra Duca; Jingli Cao
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-02-03       Impact factor: 10.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.